Open and transparent ? Read our concerns over the WHO Expert Working Group process
Treating Too Few, Too Late Read about the case for starting ARV treatment earlier in developing countries click here
An ideal TB test ? Read interview with Access Campaign director
Job openings at the Campaign We are looking for a Medical Innovation Policy Adviser and an EU Policy Advocacy Assistant Read more
|
 |
|
 |
|
 |
|
Generics to open up flu treatment If the influenza virus spreads to developing countries, many may find they don't have adequate treatments available. Patent blockages musn't be allowed to deny access to life-saving medicines whether for influenza, HIV, TB or other diseases. Read more |
|
Thailand issued compulsory licenses on AIDS drugs in order to be able to treat more patients. Hear Dr.Suwit Wibulpolprasert of the Thai Ministry of Public Health talk about the experience |
|
Have a look at these animations explaining why people in developing countries can’t get the HIV medicines they need to survive and how setting up a ’patent pool’ could change that. MSF calls on researchers and pharmaceutical companies to act: put your patents in the pool! Click here |
|
Ellen 't Hoen, former Director of Policy at the MSF Access Campaign, launches her new book, The Global Politics of Pharmaceutical Monopoly Power - Drug patents, access, innovation and the application of the WTO Doha Declaration on TRIPS and Public Health. Read more and download the book. |
|
Counterfeit, substandard and generic drugs: the need for clarity
MSF is faced with the problem of medicines that do not meet quality standards.
Read what we propose to improve the situation. 
Confusing counterfeit, substandard and generic medicines can have serious repercussions on access to medicines.
Ellen ‘t Hoen, former Policy Director at MSF, explains why.
The lack of clarity around what constitutes a counterfeit medicine in a new Kenyan law could harm access to essential medicines.
Meet the Activist: Leena Menghaney
Leena Menghaney is a lawyer by training and works for the Access Campaign in New Delhi. Currently she is working with other civil society groups on patent oppositions to newer HIV drugs Read more |
